Copper peptides work through three mechanisms: VEGF-driven angiogenesis around follicles, TGF-1 inhibition to extend anagen phase, and lysyl oxidase activation for extracellular matrix reinforcement
Increases the formation of new blood vessels by upregulating VEGF (vascular endothelial growth factor)
For anyone using BPC-157 under professional supervision, a chart may help track: Time of administration Route of administration Response over time Side effects or tolerability changes Training, rehab, or symptom patterns Adjusting for Bodyweight and Goals Bodyweight, injury severity, gastrointestinal symptoms, and recovery goals may influence how a clinician evaluates peptide use
The main Phase 3 dose steps include 2mg, 4mg, 6mg, 9mg and 12mg, with 12mg being the highest dose currently studied in major obesity trials